Dipartimento Oncologico - Ospedale S.Maria delle Croci

Ravenna, Italy
Government hospital in Ravenna
Viale Vincenzo Randi, 5, 48121 Ravenna RA

About Dipartimento Oncologico - Ospedale S.Maria delle Croci


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
14
Hoffmann-La Roche
12
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
4
Fondazione Ricerca Traslazionale
3
Incyte Corporation
1
Total Rows: 5

Clinical Trials at Dipartimento Oncologico - Ospedale S.Maria delle Croci


During the past decade, Dipartimento Oncologico - Ospedale S.Maria delle Croci conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4433553300331100111122111100Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
2008-04-01
2016-02-01
Completed
150
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
2010-04-01
2017-10-31
Completed
76
Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
2012-10-01
2017-03-11
Completed
35
Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib
2012-09-13
2016-11-24
Completed
19
Nilotinib in PH+, BCR-, ABL+ CML Patients
2012-01-01
2018-04-27
Completed
109
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436

Rows per page:

1–34 of 34

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 14 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 4 trials sponsored, "Fondazione Ricerca Traslazionale" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" #1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator, "Clinical research technology Srl" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGruppo Italiano MalattieEMatologichedell'Adulto: 14Gruppo Italiano MalattieEMatologichedell'Adulto: 14Hoffmann-La Roche: 12Hoffmann-La Roche: 12Istituto ScientificoRomagnolo per loStudio e la cura deiTumori: 4Istituto ScientificoRomagnolo per loStudio e la cura deiTumori: 4Fondazione RicercaTraslazionale: 3Fondazione RicercaTraslazionale: 3Incyte Corporation: 1Incyte Corporation: 1

Created with Highcharts 11.1.0Top CollaboratorsClinical ResearchTechnology S.r.l.: 1Clinical ResearchTechnology S.r.l.: 1Clinical researchtechnology Srl: 1Clinical researchtechnology Srl: 1Exelixis: 1Exelixis: 1Jazz Pharmaceuticals: 1Jazz Pharmaceuticals: 1

Clinical Trials Conditions at Dipartimento Oncologico - Ospedale S.Maria delle Croci


According to Clinical.Site data, the most researched conditions in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Chronic Myeloid Leukemia" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials), "BCR-ABL Positive" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" in a lesser frequency.

Clinical Trials Intervention Types at Dipartimento Oncologico - Ospedale S.Maria delle Croci


Most popular intervention types in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are "Drug" (32 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Gemcitabine" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Dipartimento Oncologico - Ospedale S.Maria delle Croci


The vast majority of trials in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are 33 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Dipartimento Oncologico - Ospedale S.Maria delle Croci


Currently, there are NaN active trials in "Dipartimento Oncologico - Ospedale S.Maria delle Croci". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Dipartimento Oncologico - Ospedale S.Maria delle Croci, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Dipartimento Oncologico - Ospedale S.Maria delle Croci, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 14Phase 2: 14Phase 3: 13Phase 3: 13Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 14Completed: 14Active, not recruiting: 11Active, not recruiting: 11Unknown status: 4Unknown status: 4Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2